• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一般实践中,使用即时检测 N 末端 pro B 型利钠肽检测对貌似健康的猫进行心脏疾病筛查。

Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice.

机构信息

Cardiospecial Veterinary Hospital, Taipei, Taiwan, ROC.

Department of Companion Animals, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada.

出版信息

J Vet Intern Med. 2021 Jul;35(4):1663-1672. doi: 10.1111/jvim.16156. Epub 2021 May 16.

DOI:10.1111/jvim.16156
PMID:33993546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8295655/
Abstract

BACKGROUND

Point-of-care (POC) N-terminal pro B-type natriuretic peptide (NT-proBNP) ELISA test has been evaluated for screening cats for cardiac disease in the referral veterinary setting but less is known about its use in general practice (GP).

OBJECTIVES

To evaluate the diagnostic utility of a POC NT-proBNP ELISA in cats seen in GPs.

ANIMALS

Two hundred and seventeen apparently healthy cats from 21 GPs.

METHODS

This was a prospective, cross-sectional study. Cardiac auscultation and POC NT-proBNP ELISA were done by veterinarians at their GPs. After enrollment at GPs, cats were sent to a cardiology referral hospital for cardiac auscultation and echocardiographic diagnosis. Results were interpreted based on whether cats had normal or abnormal echocardiographic findings.

RESULTS

Point-of-care NT-proBNP ELISA results differentiated cats in the abnormal group from those in the normal group with a sensitivity of 43%, specificity of 96%. In cats with a heart murmur at GPs, POC NT-proBNP ELISA results differentiated cats in the abnormal group from those in the normal group with a sensitivity of 71% and a specificity of 92%.

CONCLUSION AND CLINICAL IMPORTANCE

In apparently healthy cats in GPs, positive POC NT-proBNP results are associated with heart disease, warranting an echocardiogram, but negative results do not reliably exclude heart disease. These results suggest POC NT-proBNP is not an effective screening test for apparently healthy cats in GPs, although its performance is improved if it is used only in cats that have a heart murmur.

摘要

背景

床边即时检测(POC)N 端脑利钠肽前体(NT-proBNP)ELISA 检测已被用于筛选兽医转诊环境中患有心脏病的猫,但在一般实践(GP)中使用的情况知之甚少。

目的

评估 POC NT-proBNP ELISA 在 GP 中用于检查猫的心脏疾病的诊断效用。

动物

21 名兽医在 21 名 GP 处检查的 217 只貌似健康的猫。

方法

这是一项前瞻性的横断面研究。兽医在 GP 处进行心脏听诊和 POC NT-proBNP ELISA。在 GP 处登记后,将猫送往心脏病转诊医院进行心脏听诊和超声心动图诊断。结果根据猫是否有正常或异常的超声心动图结果进行解释。

结果

POC NT-proBNP ELISA 结果可将异常组的猫与正常组的猫区分开来,敏感性为 43%,特异性为 96%。在 GP 处有心脏杂音的猫中,POC NT-proBNP ELISA 结果可将异常组的猫与正常组的猫区分开来,敏感性为 71%,特异性为 92%。

结论和临床意义

在 GP 中貌似健康的猫中,阳性 POC NT-proBNP 结果与心脏病相关,需要进行超声心动图检查,但阴性结果不能可靠地排除心脏病。这些结果表明,POC NT-proBNP 不是 GP 中貌似健康的猫的有效筛查试验,尽管如果仅在有心脏杂音的猫中使用,其性能会有所提高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/c184f89f9c25/JVIM-35-1663-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/027fb201601e/JVIM-35-1663-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/d0cfee955446/JVIM-35-1663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/9558ad8bbb35/JVIM-35-1663-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/c184f89f9c25/JVIM-35-1663-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/027fb201601e/JVIM-35-1663-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/d0cfee955446/JVIM-35-1663-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/9558ad8bbb35/JVIM-35-1663-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/085e/8295655/c184f89f9c25/JVIM-35-1663-g002.jpg

相似文献

1
Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice.在一般实践中,使用即时检测 N 末端 pro B 型利钠肽检测对貌似健康的猫进行心脏疾病筛查。
J Vet Intern Med. 2021 Jul;35(4):1663-1672. doi: 10.1111/jvim.16156. Epub 2021 May 16.
2
Investigation of an N-Terminal Prohormone of Brain Natriuretic Peptide Point-of-Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease.脑钠肽N端前体激素即时检验酶联免疫吸附测定在临床正常猫和患有心脏病的猫中的研究。
J Vet Intern Med. 2017 Jul;31(4):994-999. doi: 10.1111/jvim.14776. Epub 2017 Jun 15.
3
Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation.一项多中心研究,旨在评估一种即时检测NT-proBNP的酶联免疫吸附测定法,以检测因心脏评估而转诊的猫中中度至重度隐匿性(临床前期)猫心脏病。
J Vet Cardiol. 2014 Dec;16(4):245-55. doi: 10.1016/j.jvc.2014.09.002. Epub 2014 Oct 18.
4
Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements.使用第二代定量和即时检测NT-proBNP测量法鉴别猫的心源性与非心源性胸腔积液
J Vet Intern Med. 2016 Mar-Apr;30(2):536-42. doi: 10.1111/jvim.13831. Epub 2016 Jan 27.
5
Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.评估一种用于区分猫胸腔积液的心脏性与非心脏性病因的N末端B型利钠肽原(NT-proBNP)床旁检测方法。
BMC Vet Res. 2017 Dec 20;13(1):394. doi: 10.1186/s12917-017-1319-6.
6
Evaluation of point-of-care thoracic ultrasound and NT-proBNP for the diagnosis of congestive heart failure in cats with respiratory distress.即时检测胸部超声和N末端脑钠肽前体在诊断呼吸窘迫猫充血性心力衰竭中的应用评估
J Vet Intern Med. 2018 Sep;32(5):1530-1540. doi: 10.1111/jvim.15246. Epub 2018 Sep 14.
7
Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.猫的特征对血浆 N-末端前脑钠肽 B 型利钠肽浓度的影响及即时检测与 ELISA 检测的比较。
J Vet Intern Med. 2020 May;34(3):1187-1197. doi: 10.1111/jvim.15754. Epub 2020 Mar 22.
8
Effect of NT-pro-BNP assay on accuracy and confidence of general practitioners in diagnosing heart failure or respiratory disease in cats with respiratory signs.NT-pro-BNP 检测对全科医生诊断具有呼吸症状的猫心力衰竭或呼吸疾病的准确性和信心的影响。
J Vet Intern Med. 2012 May-Jun;26(3):542-6. doi: 10.1111/j.1939-1676.2012.00916.x. Epub 2012 Mar 28.
9
Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.多中心评估血浆 N 末端脑利钠肽前体(NT-proBNP)作为猫无症状(隐匿性)心肌病的生化筛选试验。
J Vet Intern Med. 2011 Sep-Oct;25(5):1010-6. doi: 10.1111/j.1939-1676.2011.00776.x. Epub 2011 Aug 30.
10
Analytical validation of an immunoassay for the quantification of N-terminal pro-B-type natriuretic peptide in feline blood.用于定量猫血液中N端前B型利钠肽的免疫测定法的分析验证
J Vet Diagn Invest. 2015 Jul;27(4):414-21. doi: 10.1177/1040638715588330. Epub 2015 Jun 15.

引用本文的文献

1
Myocarditis in Cats with Feline Infectious Peritonitis Can Be Cured with GS-441524 and Symptomatic Cardiovascular Treatment.患有猫传染性腹膜炎的猫的心肌炎可用GS-441524及对症心血管治疗治愈。
Animals (Basel). 2025 Jun 4;15(11):1660. doi: 10.3390/ani15111660.
2
Evolving FATE: A New Lens on the Pathogenesis and Management of Feline Cardiogenic Arterial Thromboembolism.不断演变的命运:猫心源性动脉血栓栓塞症发病机制与治疗的新视角
Animals (Basel). 2025 Jun 1;15(11):1630. doi: 10.3390/ani15111630.
3
Clinical-Diagnostic and Therapeutic Advances in Feline Hypertrophic Cardiomyopathy.

本文引用的文献

1
ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats.ACVIM 共识声明指南:猫心肌病的分类、诊断和管理。
J Vet Intern Med. 2020 May;34(3):1062-1077. doi: 10.1111/jvim.15745. Epub 2020 Apr 3.
2
The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats.使用心脏超声聚焦技术筛查无症状猫的隐匿性心脏病。
J Vet Intern Med. 2019 Sep;33(5):1892-1901. doi: 10.1111/jvim.15549. Epub 2019 Jul 17.
3
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats.
猫肥厚性心肌病的临床诊断与治疗进展
Vet Sci. 2025 Mar 19;12(3):289. doi: 10.3390/vetsci12030289.
4
Genetic Basis of Hypertrophic Cardiomyopathy in Cats.猫肥厚型心肌病的遗传基础
Curr Issues Mol Biol. 2024 Aug 12;46(8):8752-8766. doi: 10.3390/cimb46080517.
5
The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.猫心肌病:2. 肥厚型心肌病。
J Feline Med Surg. 2021 Nov;23(11):1028-1051. doi: 10.1177/1098612X211020162.
6
The Feline Cardiomyopathies: 1. General concepts.猫心肌病:1. 一般概念。
J Feline Med Surg. 2021 Nov;23(11):1009-1027. doi: 10.1177/1098612X211021819.
美国兽医内科学会共识声明:犬猫系统性高血压的识别、评估及管理指南
J Vet Intern Med. 2018 Nov;32(6):1803-1822. doi: 10.1111/jvim.15331. Epub 2018 Oct 24.
4
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.评估临床前肥厚型心肌病猫和明显健康猫的心血管风险及评估长期健康状况的国际合作研究:REVEAL研究。
J Vet Intern Med. 2018 May;32(3):930-943. doi: 10.1111/jvim.15122. Epub 2018 Apr 16.
5
Transient Myocardial Thickening in Cats Associated with Heart Failure.猫心力衰竭相关的短暂性心肌增厚
J Vet Intern Med. 2018 Jan;32(1):48-56. doi: 10.1111/jvim.14897. Epub 2017 Dec 15.
6
Investigation of an N-Terminal Prohormone of Brain Natriuretic Peptide Point-of-Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease.脑钠肽N端前体激素即时检验酶联免疫吸附测定在临床正常猫和患有心脏病的猫中的研究。
J Vet Intern Med. 2017 Jul;31(4):994-999. doi: 10.1111/jvim.14776. Epub 2017 Jun 15.
7
Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study).780只待领养中心的表面健康猫的心肌病患病率(猫扫描研究)
J Vet Cardiol. 2015 Dec;17 Suppl 1:S244-57. doi: 10.1016/j.jvc.2015.03.008.
8
Screening for hypertrophic cardiomyopathy in cats.猫肥厚型心肌病的筛查。
J Vet Cardiol. 2015 Dec;17 Suppl 1:S134-49. doi: 10.1016/j.jvc.2015.07.003.
9
Analytical validation of an immunoassay for the quantification of N-terminal pro-B-type natriuretic peptide in feline blood.用于定量猫血液中N端前B型利钠肽的免疫测定法的分析验证
J Vet Diagn Invest. 2015 Jul;27(4):414-21. doi: 10.1177/1040638715588330. Epub 2015 Jun 15.
10
Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation.一项多中心研究,旨在评估一种即时检测NT-proBNP的酶联免疫吸附测定法,以检测因心脏评估而转诊的猫中中度至重度隐匿性(临床前期)猫心脏病。
J Vet Cardiol. 2014 Dec;16(4):245-55. doi: 10.1016/j.jvc.2014.09.002. Epub 2014 Oct 18.